Tune the channel: TRPM8 targeting in prostate cancer

Autor: Marco Lorenzoni, Alessandro Alaimo, Andrea Lunardi, Sacha Genovesi, Dario De Felice

Publikováno v: Oncoscience

The therapeutic landscape of cancer treatments is quickly evolving thanks to the advent of precision oncology. Discovery of novel druggable targets and more reliable biomarkers is a primary objective towards personalized strategies of cancer treatmen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f635e98edb0bc90416c3632d59fe7eb
http://europepmc.org/articles/PMC8428510

The effect of loss of mismatch repair gene expression on survival for patients with high risk endometrial cancer

Autor: Black, M., Davis, J., Terada, L., Shimizu, D.

Publikováno v: In Gynecologic Oncology July 2013 130(1):e84-e86

Risk factors for omental metastasis in clinical stage I endometrial cancer: A meta-analysis

Autor: Silasi, D., Ratner, E., Santin, A., Azodi, M., Rutherford, T., Schwartz, P.

Publikováno v: In Gynecologic Oncology July 2013 130(1):e67-e67

Tune the channel: TRPM8 targeting in prostate cancer.

Autor: Alaimo A; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento 38123, Italy., De Felice D; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento 38123, Italy., Genovesi S; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento 38123, Italy., Lorenzoni M; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento 38123, Italy., Lunardi A; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento 38123, Italy.

Publikováno v: Oncoscience [Oncoscience] 2021 Sep 10; Vol. 8, pp. 97-100. Date of Electronic Publication: 2021 Sep 10 (Print Publication: 2021).